PA2G4 and prostate carcinoma: We found that the higher expression of GNL3, CHCHD8, PA2G4, and RRP9 genes with HR more than 1.0 was closely associated with poor overall survival (Figure 2A–D) and disease-free survival in prostate cancer patients (Figure 3A–D).